CCL2 and neoplasm: Moreover, increasing the expression of monocyte chemoattractant protein-1 (MCP-1), stimulating PMNs reprogramming, and promoting a protective PMN-dependent recruitment are potential ways that RvD1 inhibits tumor growth [100].